CJC-1295 & Ipamorelin 2026: GH-Axis Trial Data, Dosage & FDA Status

CJC-1295 and Ipamorelin are among 2026's most-searched GH-axis research peptides. Here's the Teichman and Raun trial data, the real FDA Category 2 removal timeline, WADA status, and dosage protocols reported in the literature.